Eton Pharmaceuticals (ETON) Operating Margin (2019 - 2025)
Eton Pharmaceuticals (ETON) reported Operating Margin of 11.58% for Q4 2025, up 618.0% on a YoY basis from 1.61% in Q4 2024, and up 290.78% sequentially from 6.07% in Q3 2025.
Eton Pharmaceuticals (ETON) Operating Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of Operating Margin data on file, last reported at 11.58% in Q4 2025.
- For the quarter ending Q4 2025, Operating Margin rose 618.0% year-over-year to 11.58%; the trailing twelve-month figure through Dec 2025 stood at 1.06% (up 560.0% YoY), and the FY2025 full-year result was 1.06%, up 560.0% from the prior year.
- Operating Margin rose to 11.58% in Q4 2025, from 6.07% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 45.08% in Q1 2021 to a low of 754.45% in Q3 2021.
- A 5-year average of 56.83% and a median of 7.24% in 2023 frame the typical range for Operating Margin.
- Peak annual rise in Operating Margin reached 2261419 bps in 2021, while the deepest fall reached 24731177 bps in 2021.
- Tracing ETON's Operating Margin over 5 years: stood at 21.57% in 2021, then plunged by 42 bps to 12.5% in 2022, then tumbled by 154 bps to 6.69% in 2023, then soared by 181 bps to 5.4% in 2024, then surged by 114 bps to 11.58% in 2025.
- Business Quant data shows ETON's Operating Margin at 11.58% in Q4 2025, 6.07% in Q3 2025, and 7.79% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 11.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.58% |
| Sep 30, 2025 | -6.07% |
| Jun 30, 2025 | -7.79% |
| Mar 31, 2025 | -2.72% |
| Dec 31, 2024 | 5.40% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -10.04% |
| Dec 31, 2023 | -6.69% |
| Sep 30, 2023 | -7.80% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | -47.78% |
| Dec 31, 2022 | 12.50% |
| Sep 30, 2022 | -57.90% |
| Jun 30, 2022 | -26.80% |
| Mar 31, 2022 | -233.78% |
| Dec 31, 2021 | 21.57% |
| Sep 30, 2021 | -754.45% |
| Jun 30, 2021 | -75.81% |
| Mar 31, 2021 | 45.08% |